Therapeutic AreaFormulary ChoicesCost for 28
(unless otherwise stated)
Rationale for decision / comments
4.5 CNS stimulants and drugs used for attention defecit hyperactivity disorder
Treatment of ADHDSee NICE CG72 Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults (Sep-08; last modified Mar-13).
AMBER prescribing only: Initiated by a suitable specialist for the treatment of ADHD in accordance with the shared care guideline.
Methylphenidate5mg tablet: £3.03 (30)
10mg tablet: £5.49 (30)
20mg tablet: £10.92 (30)
Modified release
as Matoride XL®



as Xenidate XL®





as Xaggitin XL®





as Delmosart®
18mg yellow tablet: £15.58 (30)
36mg white tablet: £21.22 (30)
54mg red tablet: £36.80 (30)
Sust-release f-c tablet

18mg tablet: £15.62 (30)
27mg tablet: £18.52 (30)
36mg tablet: £21.24 (30)
54mg tablet: £23.69 (30);
Sust-release tabs

18mg tablet: £15.58 (30)
27mg tablet: £18.40(30)
36mg tablet: £21.22(30)
54mg tablet: £36.80 (30)
prolonged release tablets

18mg tablet: £15.59 (30)
27mg tablet: £18.41 (30)
36mg tablet: £21.23 (30)
54mg tablet: £36.81 (30)
prolonged release tablets
Matoride XL® is brand of choice for Somerset Partnership trust. No 27mg available



Xenidate XL, Matoride XL, Xaggitin XL and Delmosart are considered bioequivalent to Concerta XL
Atomoxetine10mg capsule: £53.09
18mg capsule: £53.09
25mg capsule: £53.09
40mg capsule: £53.09
60mg capsule: £53.09
80mg capsule: £70.79
100mg capsule: £70.79
Dexamfetamine
as Amfexa®
5mg tablet: £19.89
10mg tablet £39.78
20mg tablet: £79.56
Lisdexamfetamine30mg capsule: £58.24
50mg capsule: £68.60
70mg capsule: £83.16
Prodrug of dexamfetamine.